New York, New York–(Newsfile Corp. – October 5, 2020) – The following statement is being issued by Levi & Korsinsky, LLP:

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7091/65213_5134e5c474e31b01_001full.jpg

To: All Persons or Entities who purchased BridgeBio Pharma, Inc. (“BridgeBio” or the “Company”) (NASDAQ: BBIO) stock prior to October 5, 2020.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of BridgeBio with Eidos Therapeutics, Inc. (“Eidos”) (NASDAQ: EIDX). Under the terms of the merger, BridgeBio has agreed to acquire all of the outstanding common stock of Eidos it does not already own, representing approximately 36.3% of Eidos’ outstanding shares. Eidos stockholders will have the right to receive in the transaction, at their election, either 1.85 shares of BridgeBio common stock or $73.26 in cash per Eidos share in the transaction. To learn more about the action and your rights, go to:

https://www.zlk.com/mna2/bridgebio-pharma-inc-information-request-form

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500. There is no cost or obligation to you.

The BridgeBio merger investigation concerns whether the Board of BridgeBio has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/65213